Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Combinatorial ligand-directed lung targeting.

Giordano RJ, Edwards JK, Tuder RM, Arap W, Pasqualini R.

Proc Am Thorac Soc. 2009 Aug 15;6(5):411-5. doi: 10.1513/pats.200903-014AW.

2.

From combinatorial chemistry to cancer-targeting peptides.

Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, Lam KS.

Mol Pharm. 2007 Sep-Oct;4(5):631-51. Epub 2007 Sep 20. Review.

PMID:
17880166
3.

In vivo phage display and vascular heterogeneity: implications for targeted medicine.

Trepel M, Arap W, Pasqualini R.

Curr Opin Chem Biol. 2002 Jun;6(3):399-404. Review.

PMID:
12023122
4.

Vascular targeting with phage peptide libraries.

Pasqualini R.

Q J Nucl Med. 1999 Jun;43(2):159-62. Review.

PMID:
10429511
5.

Molecular addresses of tumors: selection by in vivo phage display.

Li XB, Schluesener HJ, Xu SQ.

Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):177-81. Epub 2006 May 31. Review.

PMID:
16736105
6.

Combinatorial discovery of tumor targeting peptides using phage display.

Landon LA, Deutscher SL.

J Cell Biochem. 2003 Oct 15;90(3):509-17.

PMID:
14523985
7.

Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors.

Balestrieri ML, Napoli C.

Eur J Cancer. 2007 May;43(8):1242-50. Epub 2007 Apr 20. Review.

PMID:
17449238
8.

Phage peptide display.

Newton J, Deutscher SL.

Handb Exp Pharmacol. 2008;(185 Pt 2):145-63. doi: 10.1007/978-3-540-77496-9_7. Review.

PMID:
18626602
9.

Phenotypic diversity of the lung vasculature in experimental models of metastases.

Oh Y, Mohiuddin I, Sun Y, Putnam JB Jr, Hong WK, Arap W, Pasqualini R.

Chest. 2005 Dec;128(6 Suppl):596S-600S. Review.

PMID:
16373855
10.

Combinatorial vascular targeting in translational medicine.

Staquicini FI, Moeller BJ, Arap W, Pasqualini R.

Proteomics Clin Appl. 2010 Jul;4(6-7):626-32. doi: 10.1002/prca.200900213. Epub 2010 Mar 24. Review.

PMID:
21137081
11.

Mapping tumor vascular diversity by screening phage display libraries.

Zurita AJ, Arap W, Pasqualini R.

J Control Release. 2003 Aug 28;91(1-2):183-6. Review.

PMID:
12932650
12.

Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo.

Yang Yu, Zizheng Wang, Tongxin Du.

J Biomol Screen. 2008 Dec;13(10):968-74. doi: 10.1177/1087057108326537. Epub 2008 Oct 31.

PMID:
18978306
13.

Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.

Lee TY, Lin CT, Kuo SY, Chang DK, Wu HC.

Cancer Res. 2007 Nov 15;67(22):10958-65.

14.
15.

Vascular targeting: recent advances and therapeutic perspectives.

Hajitou A, Pasqualini R, Arap W.

Trends Cardiovasc Med. 2006 Apr;16(3):80-8. Review.

PMID:
16546688
16.

Targeting tumor vasculature with homing peptides from phage display.

Ruoslahti E.

Semin Cancer Biol. 2000 Dec;10(6):435-42. Review.

PMID:
11170865
17.

Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides.

Trepel M, Pasqualini R, Arap W.

Methods Enzymol. 2008;445:83-106. doi: 10.1016/S0076-6879(08)03004-8.

PMID:
19022056
18.

Cancer-specific ligands identified from screening of peptide-display libraries.

Mori T.

Curr Pharm Des. 2004;10(19):2335-43. Review.

PMID:
15279612
19.

Identification of receptor ligands with phage display peptide libraries.

Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R.

J Nucl Med. 1999 May;40(5):883-8. Review.

20.

Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse.

Giordano RJ, Lahdenranta J, Zhen L, Chukwueke U, Petrache I, Langley RR, Fidler IJ, Pasqualini R, Tuder RM, Arap W.

J Biol Chem. 2008 Oct 24;283(43):29447-60. doi: 10.1074/jbc.M804595200. Epub 2008 Aug 21.

Supplemental Content

Support Center